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OBJECTIVES This randomized trial compared a strategy of predischarge coronary angiography (CA) with
exercise treadmill testing (ETT) in low-risk patients in the chest pain unit (CPU) to reduce
repeat emergency department (ED) visits and to identify additional coronary artery disease
(CAD).
BACKGROUND Patients with chest pain and normal electrocardiograms (ECGs) have a low likelihood of
CAD and a favorable prognosis, but they often seek repeat evaluations in EDs. Remaining
uncertainty regarding their symptoms and diagnosis may cause much of this recidivism.
METHODS A total of 248 patients with no ischemic ECG changes triaged to a CPU were randomized
to CA (n 5 123) or ETT (n 5 125). All patients had a probability of myocardial infarction
#7% according to the Goldman algorithm, no biochemical evidence of infarction, the ability
to exercise and no previous documented CAD. Patients were followed up for $1 year and
surveyed regarding their chest pain self-perception and utility of the index evaluation.
RESULTS Coronary angiography showed disease ($50% stenosis) in 19% and ETT was positive in 7%
of the patients (p 5 0.01). During follow-up (374 6 61 days), patients with a negative CA
had fewer returns to the ED (10% vs. 30%, p 5 0.0008) and hospital admissions (3% vs. 16%,
p 5 0.003), compared with patients with a negative/nondiagnostic ETT. The latter group
was more likely to consider their pain as cardiac-related (15% vs. 7%), to be unsure about its
etiology (38% vs. 26%) and to judge their evaluation as not useful (39% vs. 15%) (p , 0.01
for all comparisons).
CONCLUSIONS In low-risk patients in the CPU, a strategy of CA detects more CAD than ETT, reduces
long-term ED and hospital utilization and yields better patient satisfaction and understand-
ing of their condition. (J Am Coll Cardiol 2001;37:2042–9) © 2001 by the American
College of Cardiology
Recent reports in the media portray a decline in the public’s
perception of the capability of emergency departments
(EDs) to provide rapid and effective care, as a result of an
overburdened system (1). Chest pain symptoms alone ac-
count for more than five million patient visits annually to
EDs (2). However, objective electrocardiographic (ECG)
evidence of myocardial ischemia is present in only slightly
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more than one fourth of these patients, and a final diag-
nosis of an acute coronary syndrome is made in less than one
fifth (3,4). Therefore, in recent years, the concept of chest
pain units (CPUs) has been popularized as a rapid, effica-
cious and cost-effective alternative to in-patient hospital
admissions for those patients without ischemic ECG
changes and a low probability of myocardial infarction (MI)
(5,6). Although rapid evaluation of these patients, utilizing
sensitive biochemical markers of myocardial injury and
predischarge exercise treadmill testing (ETT), is now com-
mon practice, it remains uncertain whether such protocols
adequately test for the presence of underlying coronary
artery disease (CAD) (7–9). This uncertainty is reflected by
the fact that as many as 21% of ED chest pain evaluations
are for repeat visits within six months of the initial presen-
tation (10,11).
The present study addresses two important issues related
to this current practice. First, what are the prevalence and
angiographic features of CAD in low-risk patients with
chest pain? Second, will a negative invasive diagnostic
strategy reduce the uncertainty among patients and physi-
cians and result in fewer returns to the ED and hospital
admissions? A prospective, randomized design was used to
compare in-hospital and one-year outcomes using predis-
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charge CA versus ETT after ruling out MI in a CPU
setting.
METHODS
Design and patient selection. This trial was conducted at
the University of Texas Medical Branch at Galveston, a
public teaching hospital. Patient screening and enrollment
occurred, and informed consent was obtained in the hospi-
tal’s CPU from November 1995 through February 1997.
Inclusion criteria were age 20 to 65 years; low probability
(#7%) of acute MI, according to the Goldman algorithm
(12); absence of new ST segment or T wave changes
diagnostic or suggestive of ischemia; no evidence of isch-
emia or injury, as assessed by biochemical markers (creatine
kinase, MB fraction mass ,5 ng/ml and cardiac troponin T
,0.2 ng/ml by qualitative testing) at $10 h from symptom
onset; the ability to exercise; and no previous documented
CAD. In addition, patients who had previous CA within
the past four years, noninvasive testing for CAD within the
past two years or ECG confounders for ETT interpretation
(left bundle branch block, left ventricular hypertrophy with
strain or ventricular paced rhythm) were also excluded.
Among 550 consecutive patients screened, 248 met the
entry criteria and agreed to be randomized to either CA or
ETT. Patients were considered for randomization when
either test could be performed within 24 h of presentation.
Therefore, patients presenting between Sunday evening and
Friday were eligible for enrollment. The Institutional Re-
view Board approved the project. Written, informed con-
sent was obtained from each patient.
Intervention and management. Data on demographics,
risk factors and the quality of chest pain were collected in a
prospective, standardized manner before diagnostic testing.
The details of medication use, including anti-ischemic
drugs, gastric acid inhibitors and psychotropic medications,
were also recorded.
After consent, patients were randomized to ETT or CA.
The patients assigned to ETT were evaluated using a
symptom-limited, standard or modified Bruce protocol. A
cardiologist not involved in the study interpreted the tests.
The ETT was considered positive if $0.1 mV of new
horizontal or downsloping ST segment depression or ST
segment elevation .60 ms beyond the J point occurred
during exercise or recovery in two or more contiguous leads.
A nondiagnostic test was defined as a negative ETT with a
peak heart rate ,85% of the age-predicted maximal heart
rate. However, the results from patients who did not achieve
the target heart rate, but who completed $10 metabolic
equivalents, were also considered as negative because we
anticipated that this low-risk chest pain population would
include young, physically fit individuals. Patients with
positive exercise results were referred to CA at the discretion
of the attending physician. Patients with negative/
nondiagnostic ETTs were discharged without further in-
patient evaluation.
For patients randomized to CA, the procedure was
performed using a standard femoral approach. In the pres-
ence of CAD, decisions regarding revascularization were
made by the attending physician. Patients with normal
angiograms were observed for ;6 h before discharge. All
angiographic results of this study were obtained by quanti-
tative off-line analysis. Coronary artery disease was defined
as “moderate” when there was 50% to 69% lumen narrowing
of a major epicardial artery or its branches, or as “severe”
when there was $70% diameter stenosis. Angiographic
lesion features, including length, calcification, thrombus and
complexity, were analyzed by two independent observers,
using previously reported definitions (8,13).
All patients were seen before discharge by one of the
investigators. Patients with a normal CA or a negative ETT
were told that they had no noteworthy CAD and that their
prognosis was excellent. Patients with nondiagnostic ETTs
were told that although they did not achieve their target
heart rate, based on their exercise capacity and the absence
of ECG findings, the probability of a cardiac ischemic
etiology for their symptoms was very low and their discom-
fort did not necessitate worry or require any limitations of
daily activities. For all patients, a letter summarizing the test
results and discharge diagnosis was sent to the patients’
regular physicians.
Follow-up. To facilitate subsequent medical care after
discharge, all patients were offered referral to a primary care
physician if they did not have regular medical follow-up.
Patients were followed up by telephone interviews every
three months for a minimum of one year. End points
included death, MI, return to the ED with chest pain as the
chief complaint and hospital admissions for chest pain.
Medical records were reviewed to confirm the end points. In
addition, patients were queried about recurrent chest pain,
which was defined as frequent when there were four or more
episodes per month, similar in quality to the initial presen-
tation. At six months, using a standardized questionnaire,
the patients were surveyed about their current perception of
chest pain as cardiac or noncardiac and the utility of their
index cardiovascular evaluation, to provide insight into the
etiology of their symptoms.
Statistical analysis. Outcome analyses were based on the
intention-to-treat principle. Analysis of variance and chi-
square tests for multi-way contingency tables were used to
compare group differences for continuous and categorical
data, respectively. Freedom from ED returns between the
Abbreviations and Acronyms
CA 5 coronary angiography or angiogram
CAD 5 coronary artery disease
CPU 5 chest pain unit
ECG 5 electrocardiogram or electrocardiographic
ED 5 emergency department
ETT 5 exercise treadmill test or testing
MI 5 myocardial infarction
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groups was estimated by using the Kaplan-Meier survival
technique and compared using the log-rank test.
For patients with negative tests, the association between
demographic and clinical variables and the likelihood of ED
return was assessed by Cox proportional hazard analysis. To
avoid destabilizing the analyses when relatively few events
occurred, separate models were built using a stagewise
approach, with the following domains of variables: demo-
graphic characteristics, risk factors, chest pain features and
medications used (Table 1). The incremental influence of
the testing strategy on the risk of ED return visits was
assessed by adding to each model a dichotomous variable
(coded as 0 for ETT and 1 for CA) and computing the
change in the models’ chi-square value. To allow for variable
mixing and to ascertain which determinants carried the
strongest predictive power, we built a final model that
included all predictors with p # 0.10 in the former analysis,
and adjusted relative risks with 95% confidence intervals
were calculated.
For all tests, a two-sided p value ,0.05 was regarded as
significant. Computations were performed using the Statis-
tica, version 5.1 (StatSoft Inc., Tulsa, Oklahoma) software
package.
RESULTS
In-hospital outcomes. Of the 248 patients enrolled, 123
were randomized to CA and 125 to ETT. All patients
completed their assigned procedures. Figure 1 illustrates the
in-hospital outcomes of the two groups.
The exercise protocol was completed with no complica-
tions in all patients. The test was negative in 82 patients
(66%) and nondiagnostic in 34 (27%). Patients with non-
diagnostic results attained a mean heart rate of 71 6 9%
(median 73%) of the age-predicted maximum (15 had a
heart rate $75% of the age-predicted maximum); the
exercise time was 5.9 6 1.6 min (median 6.2) using a Bruce
protocol, and a mean of 10 6 3.4 min (median 10.7) using
a modified Bruce protocol. Of the nine patients (7%) with
positive test results, eight underwent CA and one declined.
Six (75%) of these eight patients had CAD, and five
underwent revascularization.
For patients undergoing CA, the procedure resulted in no
death, MI or stroke. The presence of disease was detected in
23 patients (19%), including 5 with intermediate lesions and
18 with severe stenosis. The percentage of patients with
disease on the CA was significantly greater than the
percentage of patients with a positive ETT (p 5 0.012). Of
Table 1. Prerandomization Characteristics in All Patients and Patients Grouped by Test Results
All Patients Group
(n 5 248)
Positive CA Group
(n 5 23)
Positive ETT Group
(n 5 9)
Negative CA Group
(n 5 100)
N/N ETT Group
(n 5 116)
Demographic data
Age (years) 49 6 8 53 6 8* 48 6 8 48 6 9 48 6 9
Male gender 110 (44%) 12 (52%) 5 (56%) 39 (39%) 54 (47%)
Race
White 148 (60%) 17 (74%) 3 (33%) 57 (56%) 71 (61%)
African American 66 (27%) 2 (9%) 5 (56%) 28 (28%) 31 (27%)
Hispanic 29 (12%) 4 (18%) 1 (11%) 12 (12%) 12 (10%)
Other 5 (2%) 0 0 3 (3%) 2 (2%)
Insured 179 (72%) 18 (78%) 7 (78%) 70 (70%) 84 (72%)
Cardiac risk factors
Diabetes 53 (21%) 11 (48%) 1 (11%) 19 (19%) 22 (19%)
Hypertension 125 (50%) 12 (52%) 5 (56%) 51 (51%) 57 (49%)
Smoking 127 (51%) 16 (70%) 4 (44%) 45 (45%) 62 (53%)
Hypercholesterolemia 79 (32%) 7 (30%) 4 (44%) 33 (33%) 35 (30%)
$2 Risk factors 124 (50%) 16 (70%) 4 (44%) 45 (45%) 59 (51%)
Chest pain features
Pressure 127 (51%) 15 (65%) 5 (56%) 52 (52%) 55 (47%)
Substernal 184 (74%) 19 (82%) 6 (67%) 74 (74%) 85 (73%)
Exertional 62 (25%) 6 (26%) 5 (56%) 27 (27%) 24 (21%)
Relieved by nitrates or rest 100 (40%) 13 (57%) 3 (33%) 44 (44%) 40 (34%)
Radiated to left arm 124 (50%) 11 (48%) 5 (56%) 52 (52%) 56 (48%)
Associated with SOB/
diaphoresis
182 (73%) 17 (74%) 8 (89%) 79 (79%) 78 (67%)
Medications used
Nitrates 33 (13%) 7 (32%) 1 (11%) 9 (9%) 16 (14%)
Calcium antagonists 27 (11%) 4 (17%) 2 (22%) 10 (10%) 11 (9%)
Beta-blockers 20 (8%) 2 (9%) 1 (11%) 7 (7%) 10 (9%)
H2-blockers 31 (13%) 4 (17%) 3 (33%) 11 (11%) 13 (11%)
Psychotropics 21 (8%) 2 (9%) 1 (11%) 7 (7%) 11 (9%)
*p , 0.05 vs. every other group. Data are presented as the mean value 6 SD or number (%) of patients.
CA 5 coronary angiography; ETT 5 exercise treadmill test; N/N 5 negative/nondiagnostic; SOB 5 shortness of breath.
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the 18 patients with severe stenosis determined by CA, 14
underwent coronary revascularization.
Table 1 reports the demographic and clinical character-
istics for all patients and patients grouped according to the
results of CA and ETT. Other than a slightly older mean
age in the positive-CA group, other variables were not
significantly different.
The angiographic features of the lesions were not dissim-
ilar in patients randomized to CA and ETT. Overall, the
frequencies of left main coronary artery disease, intracoro-
nary thrombus and complex lesion morphology were 6%,
4% and 45%, respectively. No significant intergroup differ-
ences in lesion location, degree of stenosis or plaque
morphologic features were observed.
Long-term outcomes. Follow-up data were available for
238 patients (96%). After 374 6 61 days (median 375),
none of the patients died, and one patient (0.4%) with a
positive CA had an acute MI.
The events for 208 of the 216 patients with negative or
nondiagnostic tests who were followed up (96%) are re-
ported in Table 2. Frequent episodes of chest pain were
reported by 29% of these patients, with a higher frequency
among patients who underwent ETT versus CA (p 5 0.04).
Among 43 patients who returned to the ED, none had
ECG or enzymatic evidence of an acute coronary event.
Patients with a negative CA had significantly fewer ED
visits and re-admissions to the hospital, compared with
patients with a negative/nondiagnostic ETT (p 5 0.0008
and p 5 0.003, respectively). In patients with a nondiag-
nostic ETT, there was no greater likelihood of ED repre-
sentation (12 [35%] of 34) or re-admission (4 [12%] of 34)
compared with patients with a negative ETT (ED returns:
Figure 1. Flow diagram of in-hospital clinical outcomes of patients randomized to coronary angiography (CA) or exercise treadmill testing. 1V 5
single-vessel disease; CABG 5 coronary artery bypass grafting; CAD 5 coronary artery disease; Meds 5 medical therapy; MV 5 multivessel disease;
PTCA 5 percutaneous transluminal coronary angioplasty.
Table 2. Follow-Up of Patients With Negative/Nondiagnostic Tests
All Patients
(n 5 208)
Negative CA
Group
(n 5 98)
N/N ETT
Group
(n 5 110)
p
Value
Death 0 0 0 —
Myocardial infarction 0 0 0 —
Frequent recurrent chest pain* 60 (29%) 21 (21%) 39 (35%) 0.04
Emergency department return
for chest pain
43 (21%) 10 (10%) 33 (30%) 0.0008
Hospitalized for chest pain 21 (10%) 3 (3%) 18 (16%) 0.003
*Four or more episodes per month. Data are expressed as number (%) of patients.
Abbreviations as in Table 1.
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21 [28%] of 76, p 5 0.55; re-admissions: 14 [18%] of 76,
p 5 0.55).
Of the 10 patients with a negative CA who returned to
the ED during one year (2 with multiple visits; 13 total
visits), only 3 were admitted to the hospital, and no further
testing for CAD was done after observation. Of the 33
patients with a negative/nondiagnostic ETT who presented
to the ED (12 with multiple visits, 48 total visits), 18 were
admitted to the hospital. Ten patients had further nonin-
vasive testing, and none were positive; but one patient with
initial nondiagnostic results underwent CA and subsequent
coronary artery bypass graft surgery. Three other patients
also underwent CA directly after observation, and none had
CAD.
The temporal distribution of first ED returns after the
index observation for patients with negative/nondiagnostic
tests is shown as Kaplan-Meier curves (Fig. 2). A difference
in the curves became apparent by 60 days after the index
observation and widened progressively throughout one year.
By one year, patients with a negative CA had a significantly
lower probability of returning to the ED, compared with
patients with a negative/nondiagnostic ETT (p 5 0.0003).
Finally, when all study patients were considered (positive
and negative results), the cumulative proportion free of ED
returns at one year still remained significantly lower for
patients randomized to ETT versus CA (69% vs. 83%; p 5
0.041).
Multivariate analysis. To discern whether factors, other
than choice of diagnostic test, may significantly influence
the probability of a patient with a negative test result
returning to the ED with chest pain, multivariate analysis
was performed. The predictive ability of four clinical models
tested, including demographic characteristics, cardiac risk
factors, chest pain features and medications used, was
significantly increased after adding the variable of random-
ization strategy, as expressed by the change in the models’
chi-square value. In all these models, randomization strat-
egy was an independent predictor (p , 0.001). Finally,
when all variables with p # 0.10 in the former models
were combined, the CA strategy was the only significant
predictor associated with a reduced likelihood of ED returns
(Fig. 3).
Follow-up questionnaire. Table 3 reports the results of
the follow-up questionnaire for 229 patients who re-
sponded. The vast majority of patients with positive tests
perceived their chest pain as cardiac and rated their index
evaluation as useful for determining chest pain etiology. In
contrast, patients with a negative/nondiagnostic ETT, ver-
sus those with a negative CA, were more than twice as likely
to still consider their symptoms to be cardiac-related (15%
vs. 7%) or were still uncertain of the etiology of their chest
pain symptoms (38% vs. 26%) (overall p , 0.01). This is
reflected in 39% of the patients with a negative/
nondiagnostic ETT, not considering their index diagnostic
procedure as useful, versus only 15% of the patients with a
negative CA (p , 0.01).
Responses to the survey were not different according to
whether the ETT was negative or nondiagnostic. In partic-
ular, the proportion of patients who found the index
evaluation not helpful in identifying the cause of their chest
pain was 41% (29 of 71) among patients with a negative
ETT, and 35% (12 of 34) among those with a nondiagnos-
tic ETT (p 5 0.74).
DISCUSSION
To the best of our knowledge, this is the first randomized
study to prospectively compare an immediate diagnostic
strategy of CA with ETT for the assessment of low-risk
patients with chest pain triaged to a short-term observation
unit. Our major findings are: 1) the prevalence of CAD
detected by CA was significantly higher than that antici-
Figure 2. Twelve-month Kaplan-Meier plot depicting temporal distribution of emergency department (ED) returns for chest pain among 208 low-risk
patients with chest pain with a negative coronary angiogram (CA) or a negative/nondiagnostic exercise treadmill test (ETT). Circles or triangles denote
end point.
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pated with ETT in this study, as well as previous studies
(14–16); and 2) a normal CA resulted in a threefold lower
incidence of ED returns and a fivefold reduction in re-
admissions for chest pain during a one-year period, com-
pared with a negative/nondiagnostic ETT.
Detection of CAD. The 19% rate of angiographic CAD is
particularly striking, as patients with a higher pretest like-
lihood of disease (age .65 years or previous documented
CAD) were specifically excluded from our study. Further-
more, coronary lesions with complex morphology, which are
frequently associated with acute coronary syndromes (13),
were a common finding (45%) in this study. This suggests
that in some patients, chest pain alone, with a clinical
low-risk presentation, represents part of the continuum of
acute coronary syndromes.
The rate of positive ETT (7%) was comparable to that
reported in previous nonrandomized studies of low-risk
patients (range 1% to 13%) (14–16). If one assumes a
similar prevalence of CAD in the two randomization arms
in the present study (given the equivalency of clinical
characteristics), the sensitivity of ETT for detecting CAD is
lower than anticipated. This may reflect an absence of
referral bias regarding CA, due to our randomized study
design, and is consistent with the reported sensitivity of
ETT for detecting CAD in other studies that have elimi-
nated referral bias to CA (7). In addition, the inclusion of
patients with moderate disease (50% to 69% stenosis) may
further lower the sensitivity of ETT to detect CAD.
Although it is likely that some of these lesions may not be
hemodynamically significant, they may ultimately predict
patients at higher risk for future MI or death (17). Thus, an
approach utilizing routine CA can offer an opportunity for
early identification of a range of CAD severities, as well as
the potential for initiation of prevention strategies to reduce
long-term cardiac morbidity and mortality (18). This initial
diagnosis may be missed by currently accepted rapid-
evaluation algorithms that utilize ETT.
Chest pain and recidivism. Although this study and oth-
ers have shown that meeting clinical criteria for a CPU
places the patient in a low-risk group for subsequent death
or MI during long-term follow-up (19), a major problem for
low-risk patients with chest pain is the frequent recurrence
Figure 3. Adjusted relative risks for factors influencing the likelihood of emergency department (ED) return with chest pain in 208 low-risk patients with
chest pain with a negative coronary angiogram or a negative/nondiagnostic exercise treadmill test. The error bars represent 95% confidence intervals, with
relative risk minimal and maximal limits indicated by numbers in parentheses.
Table 3. Results of the Follow-Up Questionnaire for 229 Patients Who Responded
Positive CA Group
(n 5 22)
Positive ETT Group
(n 5 7)
Negative CA Group
(n 5 95)
N/N ETT Group
(n 5 105)
What do you think about the cause of your
chest pain?
Cardiac 17 (77%) 5 (71%) 7 (7%) 16 (15%)
Other 3 (14%) 1 (14%) p 5 NS 63 (66%) 49 (47%) p , 0.01
Don’t know 2 (9%) 1 (14%) } 25 (26%) 40 (38%) }
Was your evaluation helpful for determining
the cause of your chest pain?
Yes 19 (86%) 6 (86%)
p 5 NS
81 (85%) 63 (60%)
p , 0.01
No 3 (14%) 1 (14%) } 14 (15%) 41 (39%) }
Data are expressed as the number (%) of patients.
Abbreviations as in Table 1.
2047JACC Vol. 37, No. 8, 2001 deFilippi et al.
June 15, 2001:2042–9 Angiography vs. Exercise Testing in Chest Pain Units
of symptoms, with repeat ED presentations and re-
admissions (10,11). Recurrence of multiple chest pain epi-
sodes was a common finding in our study, even in patients
with normal angiograms. Despite symptom persistence,
however, there was a 14% net improvement in the propor-
tion of patients free of ED returns (83% vs. 69%) in the
routine CA arm. Particularly striking was that a negative
CA, compared with a negative/nondiagnostic ETT, re-
sulted in substantially fewer admissions over the year (3 vs.
18). As re-admission in our study was not driven by strong
clinical or ECG reasons, one can surmise a lack of faith in
noninvasive testing. Thus, for both the patients evaluated
and the physicians who later provided care for these pa-
tients, the higher degree of certainty that CAD was not
present altered subsequent utilization of hospital resources.
Such a hypothesis is not without precedent, as several
retrospective studies have documented significant reduc-
tions in ED visits, re-admissions and overall resource
utilization after documentation of an absence of CAD by
CA in patients with chronic chest pain syndromes (20,21).
This interpretation is also supported by the results of our
patient survey, which identified improved patient under-
standing of their condition (as either cardiac or noncardiac
in origin) through the results of a test (i.e., CA).
Importantly, however, routine CA of our low-risk pa-
tients in the CPU led to a higher number of initial
revascularization procedures (14 vs. 6), with no beneficial
effect on “hard” end points. This is consistent with the
findings of randomized studies of medical versus percuta-
neous coronary interventional management of low- to-
moderate-risk stable patients with CAD (22,23).
Negative versus nondiagnostic ETT. For patients with a
nondiagnostic ETT, the remaining uncertainty about their
diagnosis could strongly influence their return rate. Al-
though it is possible to risk stratify low-risk patients with
chest pain by means of myocardial perfusion imaging with
technetium-99m sestamibi or stress echocardiography,
whether such tests should be performed for all low-risk
patients in the CPU or only for those with a nondiagnostic
ETT remains debatable (24). Our study confirms the safety
of discharging such patients without further work-up (15),
as there were no deaths or MIs in this group, and only one
patient was subsequently found to have CAD requiring
revascularization.
In our patients, exercise tolerance was generally good, and
the percentage of nondiagnostic results was consistent with
other studies of low-risk patients in the CPU (15,16). The
lack of difference between the nondiagnostic and negative
ETT in terms of the risk of repeat ED presentation,
re-admission or perception of the usefulness of their index
evaluation, suggests that nondiagnostic results do not spe-
cifically identify patients who would routinely benefit more
from further diagnostic testing for CAD.
Study limitations. For patients randomized to CA, evi-
dence of severe disease frequently led to a revascularization
procedure, even in the absence of objective documentation
of myocardial ischemia. The compulsion to intervene once
stenosis is identified is widely recognized (25), and the use
of interventions is particularly prevalent in our region of the
U.S. (i.e., southwestern) (26). Therefore, it is uncertain
whether some of these patients may have done as well or
better with a trial of medical therapy or an ischemia-guided
approach to revascularization.
For patients with normal angiograms, we often made an
assumption that symptoms were of noncardiac etiology.
However, a minority may have had ischemia in the absence
of angiographically significant lesions (27). Although such
patients could more frequently have recurrent symptoms,
the implications of this finding are uncertain because the
prognosis for this group of patients is excellent and no
definitive treatment exists.
For low-risk patients, CA may not be practical at many
institutions, because it is not widely available on an imme-
diate basis for nonemergent use. The invasive nature of the
procedure will also limit its acceptance for this indication.
Current guidelines recommend symptom-limited ETT dur-
ing the initial CPU assessment and consideration of CA in
“repeat presenters” with previous negative cardiac evalua-
tions and with no other identifiable sources of symptoms
(28,29). Although we did not test this specific strategy, our
data at least provide support for such an intermediate tactic.
In the future, alternative noninvasive coronary imaging
techniques may be used to accurately exclude CAD (30),
making our findings applicable for most centers.
Demographics and selection criteria may change the
prevalence of CAD in a low-risk group of patients selected
for an accelerated diagnostic protocol. Our patient selection
was protocol-driven and based on a well-established CPU
algorithm (12). Considering the results of our multivariate
analysis, the decreased repeat ED presentation rate for
patients with a negative CA should hold across a variety of
populations and demographic characteristics. However, sev-
eral factors, including different physicians’ opinions, both on
patients’ symptoms and the value of diagnostic tests per-
formed, and possible differences in postdischarge ambula-
tory care, may have influenced returns to the ED and
re-admissions. Evaluating the weight of these factors was
beyond the scope of the present study.
Finally, we chose to exclude patients .65 years old
because of their higher pretest likelihood of CAD and
potential concomitant noncardiac reasons for failing to
obtain a target heart rate on ETT. Therefore, the excellent
prognosis of our patient group may not be directly extrap-
olated to elderly patients in the CPU.
Clinical implications. When initially considered, use of
CA in low-risk patients with chest pain is contrary to the
current emphasis on reducing the utilization of in-patient
health care resources. The fact that immediate CA in the
current study detected significantly more CAD than ex-
pected, and a normal angiogram heralded reduced ED
returns and re-admissions, raises important questions as to
whether current diagnostic strategies for low-risk patients
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without biochemical evidence of MI are optimal for imme-
diate diagnosis, long-term resource utilization and patient
satisfaction. Further studies may be warranted to determine
whether there is potential long-term cost-effectiveness of a
strategy of CA early in the evaluation of low-risk patients
with chest pain observed in a CPU setting.
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